Patents by Inventor Xiao Xu

Xiao Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210324503
    Abstract: A super-tough steel and a production method thereof. The present invention belongs to the field of steels and preparation thereof, and particularly relates to a super-tough steel for cryogenic services, and a production method thereof. The super-tough steel comprises the following elements in percentage by weight: 0.10% to 0.15% of C, and 29.5% to 31.5% of Mn, with the balance being Fe and inevitable impurities. The production method comprises the following steps: A1, smelting with argon protection, and electroslag remelting; A2, hot rolling or hot forging; A, annealing at 900° C. to 1100° C. for 1 hour, and quenching; and A4, cold rolling, annealing of the cold-rolled plate at 700° C.-1200° C. for 1 hour, and quenching after annealing. The steel is simple in composition and does not contain precious metals; and the steel has an average grain size of less than 30 microns, and is non-magnetic with complete face-centered cubic structure.
    Type: Application
    Filed: June 1, 2021
    Publication date: October 21, 2021
    Applicant: YANSHAN UNIVERSITY
    Inventors: Yu Hui WANG, Xiao Xu HANG, Ya Nan ZHENG, Tian Sheng WANG, Jian Hua LIU, Yan PENG, Bo LIAO
  • Publication number: 20210300931
    Abstract: Disclosed methods of making certain pyrrolopyrimidine derivatives, which are useful in the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3(D835Y), ITK, JAK1, JAK2, JAK3, TEC AND TXK) and/or the respective pathways, salts, polymorphs, and amorphous forms of said compounds, synthetic intermediates for preparing said compounds, and pharmaceutical compositions comprising said compounds and methods for making such compositions.
    Type: Application
    Filed: April 7, 2017
    Publication date: September 30, 2021
    Applicants: ACEA Therapeutics, Inc., Hangzhou ACEA Pharmaceutical Research Co., Ltd., Zhejiang ACEA Pharmaceuticals Co., Ltd.
    Inventors: Long MAO, Jia LIU, Yile CHEN, Yuning HUA, Kongen DAI, Yimei BAO, Bojie WENG, Xi-aopeng MO, Jian WU, Xiao XU, Wanhong XU, Xiaobo WANG
  • Patent number: 11120840
    Abstract: An information processing method comprising: obtaining environment information of a video file in a preview state, where the preview state is a display state before the video file is played; in response to the environment information satisfying a first pre-set condition, indicating the video file by a first cover; and in response to the environment information satisfying a second pre-set condition, indicating the video file by a second cover.
    Type: Grant
    Filed: March 26, 2020
    Date of Patent: September 14, 2021
    Assignee: LENOVO (BEIJING) CO., LTD.
    Inventors: Xiao Xu, Dakun Yang, Jingxian Liu
  • Publication number: 20210198670
    Abstract: The present disclosure provides a method for knocking out an N-myristoyltransferase (NMT) gene from Eimeria tenella, and belongs to the technical field of microorganisms. The method includes: mixing sporozoites of Eimeria tenella with a pCRISPR::EtNMT plasmid and a pEtNMT::DHFR plasmid, and subjecting a resulting mixture to electrotransformation to obtain NMT gene-knockout Eimeria tenella. The method provided by the present disclosure can successfully knock out the NMT gene from Eimeria tenella, which lays a foundation for studying the function of the Eimeria tenella gene and developing a vaccine therefor.
    Type: Application
    Filed: December 23, 2020
    Publication date: July 1, 2021
    Inventors: Jianping CAI, Zigang QU, Xiao XU, Jing WANG, Zhenxing GONG, Heng WANG, Xueyang HE, Wenqing WANG
  • Publication number: 20210164961
    Abstract: A system for monitoring cell-substrate impedance of excitable cells at millisecond time resolution and methods of assessing cell beating by monitoring cell-substrate impedance of beating cells at millisecond time resolution.
    Type: Application
    Filed: January 3, 2020
    Publication date: June 3, 2021
    Inventors: Xiaobo Wang, Yama A. Abassi, Biao Xi, Wen Fu Zhang, Xiao Xu
  • Patent number: 11015082
    Abstract: A composition for planarizing a semiconductor device surface includes a catalyst, at least one solvent, and at least one polysiloxane resin including polysilsesquioxane blocks and polydisiloxane blocks. The polydisiloxane blocks are according to the general formula: wherein R1, R2 are each independently selected from the group consisting of: an aryl group or an alkyl group, with substituted or unsubstituted carbons.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: May 25, 2021
    Assignee: Honeywell International Inc.
    Inventors: Helen Xiao Xu, Hong Min Huang
  • Patent number: 11007197
    Abstract: The present invention relates to certain pyrrolopyrimidine derivatives, pharmaceutical compositions containing them, and methods of using them, including methods for the treatment of tumors and related diseases related to the dysregulation of kinase (such as EGFR (including HER), Alk, PDGFR, but not limited to) pathways.
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: May 18, 2021
    Assignee: ACEA THERAPEUTICS, INC.
    Inventors: Xiao Xu, Xiaobo Wang, Long Mao, Li Zhao, Biao Xi
  • Publication number: 20210100802
    Abstract: The present disclosure provides pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment of tumors and related diseases related to the dysregulation of kinase (such as EGFR (including HER), Alk, PDGFR, but not limited to) pathways.
    Type: Application
    Filed: August 24, 2020
    Publication date: April 8, 2021
    Applicant: ACEA Therapeutics, Inc.
    Inventors: Xiao XU, Xiaobo WANG, Long MAO, Li ZHAO, Biao XI
  • Publication number: 20210095334
    Abstract: The present invention provides methods of profiling gene and protein expression of a plurality of nuclei from a single cell type and comparing the profiles to determine variability among cell populations, samples from different subjects, and cells expressing a disease phenotype.
    Type: Application
    Filed: February 9, 2018
    Publication date: April 1, 2021
    Inventors: Nathaniel Heintz, Xiao Xu
  • Patent number: 10947412
    Abstract: A composition for planarizing a semiconductor device surface includes a silicon-based material and a cross-linker including a siloxane compound according to the general formula: wherein R is an aliphatic comprising group and R1, R2, R3, R4, R5, and R6 are each independently selected from the group consisting of: H or an alkyl group with substituted or unsubstituted carbons.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: March 16, 2021
    Assignee: Honeywell International Inc.
    Inventors: Hong Min Huang, Helen Xiao Xu
  • Publication number: 20210041418
    Abstract: Methods of assessing cytolysis of cancer cells are provided, which include: providing a cell-substrate impedance monitoring device operably connected to an impedance analyzer, adding target cells characterized as cancer cells to a well of the device adding effector cells to the well to form a test well, where the effector cells are immune cells obtained or derived from a same patient as the target cells; monitoring cell-substrate impedance of the test well before and after adding the effector cells and optionally deriving an impedance-based parameter from the impedance; and determining effectiveness of effector cell killing of the target cells by comparing the impedance or impedance-based curves over time.
    Type: Application
    Filed: October 29, 2020
    Publication date: February 11, 2021
    Inventors: Xiaobo Wang, Yama A. Abassi, Nan Li, Lincoln Muir, Xiao Xu
  • Publication number: 20210009957
    Abstract: Provided are a cardiomyocyte preparation, a preparation method therefor and the use of the preparation in treating heart failure. The cardiomyocyte preparation comprises cardiomyocytes and fibroblasts, differentiated from pluripotent stem cells, wherein the concentration of the cardiomyocytes in the cardiomyocyte preparation is 0.75×107-1.0×109 cells/mL, and the content of the cardiomyocytes is higher than 80% while the content of the fibroblasts is not higher than 20%. The cardiomyocyte preparation can improve cardiac ejection fraction and left ventricular fractional shortening, and increase the thickness of the left ventricular inner wall.
    Type: Application
    Filed: December 19, 2019
    Publication date: January 14, 2021
    Inventors: Jiaxian WANG, Qian WANG, Yat Ping TSUI, Xiao XU
  • Publication number: 20200388468
    Abstract: An ion source assembly and method has a source gas supply to provide a molecular carbon source gas to an ion source chamber. A source gas flow controller controls flow of the molecular carbon source gas to the ion source chamber. An excitation source excites the molecular carbon source gas to form carbon ions and radicals. An extraction electrode extracts the carbon ions from the ion source chamber, forming an ion beam. An oxidizing co-gas supply provides oxidizing co-gas to chamber. An oxidizing co-gas flow controller controls flow of the oxidizing co-gas to the chamber. The oxidizing co-gas decomposes and reacts with carbonaceous residues and atomic carbon forming carbon monoxide and carbon dioxide within the ion source chamber. A vacuum pump system removes the carbon monoxide and carbon dioxide, where deposition of atomic carbon within the ion source chamber is reduced and a lifetime of the ion source is increased.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 10, 2020
    Inventors: David Sporleder, Neil Bassom, Neil K. Colvin, Mike Ameen, Xiao Xu
  • Publication number: 20200348312
    Abstract: Methods for identifying compounds that modulate cellular responses stimulated by IgE, which include providing an impedance-based system that monitors cell-substrate impedance of cells on a substrate; introducing cells to the substrate of the system; adding at least one test compound and IgE to the cells, wherein the at least one test compound is suspected of modulating cell responses stimulated by the IgE; adding an antigen to the cells; monitoring the cell-substrate impedance of cells on the substrate; and analyzing the cell-substrate impedance to evaluate whether the at least one test compound alters a cellular response to stimulation with the IgE.
    Type: Application
    Filed: March 27, 2020
    Publication date: November 5, 2020
    Inventors: Xiao Xu, Yama A. Abassi, Xiaobo Wang, Jiangbo Gan
  • Patent number: 10810362
    Abstract: An information collection module receives an incident report request from a user of a browser running a network application on a client system to thereby provide a page in the browser. The information collection module collects incident data including user interactions with the page, client system features and operations associated with executing the network application, and a document object model (DOM) of the page. An annotation tool of the network application receives annotations of the page from the user for inclusion in the incident data, and a server-side incident manager receives the incident data. The server-side incident manager includes a rendering engine that renders the document object model and the annotations, and an incident analyzer that displays the collected user interactions, and client system features and operations, and the rendered document object model and annotations.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: October 20, 2020
    Assignee: SAP SE
    Inventors: Simon Tang, Xiao Xu, William Cui, Nate Wang, Jianrong Yu, Luis Lu, Jonny Chen, Ming-hui Cao, Walton Wang, Frank Fan, Ufo Qiao, Linda Xu
  • Patent number: 10799504
    Abstract: The present disclosure provides pharmaceutical compounds, compositions and methods, especially as they are related to compositions and methods for the treatment of tumors and related diseases related to the dysregulation of kinase (such as EGFR (including HER), Alk, PDGFR, but not limited to) pathways.
    Type: Grant
    Filed: January 12, 2013
    Date of Patent: October 13, 2020
    Assignee: ACEA THERAPEUTICS, INC.
    Inventors: Xiao Xu, Xiaobo Wang, Long Mao, Li Zhao, Biao Xi
  • Publication number: 20200312375
    Abstract: An information processing method comprising: obtaining environment information of a video file in a preview state, where the preview state is a display state before the video file is played; in response to the environment information satisfying a first pre-set condition, indicating the video file by a first cover; and in response to the environment information satisfying a second pre-set condition, indicating the video file by a second cover.
    Type: Application
    Filed: March 26, 2020
    Publication date: October 1, 2020
    Inventors: Xiao XU, Dakun YANG, Jingxian LIU
  • Publication number: 20200292037
    Abstract: A ball screw spline assembly includes: a ball screw spline including a first nut including a first mounting surface adapted to receive a first fastening element for installing the first nut to a housing; a second nut including a second mounting surface adapted to receive a second fastening element for installing the second nut to the housing; and a shaft passing through the first nut and the second nut; the housing including a first portion and a second portion, the first portion extends in a direction substantially parallel to the shaft, and the second portion extends in a direction substantially perpendicular to the shaft; a connecting plate coupling the second nut to the first portion, the first nut is installed to the second portion; the first mounting surface and the second mounting surface are located within a space defined by the first portion, the second portion and the connecting plate, such that the ball screw spline is integrally installable to the housing.
    Type: Application
    Filed: May 28, 2020
    Publication date: September 17, 2020
    Inventors: Xiao Xu, Tao Feng
  • Publication number: 20200278339
    Abstract: Extracellular recording devices with reference electrodes positioned in a cell free zone and methods of conducting extracellular recording. Parallel cell-substrate impedance monitoring and extracellular recording of excitable cells such as excitable cells, cardiomyocytes, and cardiomyocyte precursor cells using devices that switch between extracellular recording and impedance monitoring modes.
    Type: Application
    Filed: January 24, 2020
    Publication date: September 3, 2020
    Inventors: Xiaobo Wang, Wei Ouyang, Nan Li, Biao Xi, Yama A. Abassi, Xiao Xu
  • Patent number: 10725023
    Abstract: A method of identifying a therapeutic compound for treating cancer in a human subject, the method including: providing a device that measures cell-substrate impedance; culturing cancer cells in the at least two wells, wherein the cancer cells are obtained from a human subject and have a receptor tyrosine kinase (RTK) pathway; adding to a first well a proposed therapeutic compound that affects an RTK pathway and an RTK stimulating factor for the RTK pathway to form a test well, and adding to another well the RTK stimulating factor to form a control well; continuously monitoring cell-substrate impedance of the at least two wells; and determining a difference in impedance or optionally in cell index between the test well and control well; and if significantly different, concluding the proposed therapeutic compound is therapeutically active in the RTK pathway within the cancer cells of the human subject.
    Type: Grant
    Filed: December 31, 2018
    Date of Patent: July 28, 2020
    Assignee: ACEA Biosciences, Inc.
    Inventors: Yama A. Abassi, Naichen Yu, Josephine Atienza, Xiao Xu, Xiaobo Wang